Geron Corp
General ticker "GERN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6B
Geron Corp follows the US Stock Market performance with the rate: 48.4%.
Estimated limits based on current volatility of 3.6%: low 3.45$, high 3.70$
Factors to consider:
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.67$, 3.37$]
- 2024-12-30 to 2025-12-30 estimated range: [1.61$, 3.29$]
Financial Metrics affecting the GERN estimates:
- Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
- Negative: Operating profit margin, % of -99.88 <= 1.03
- Negative: Operating cash flow per share per price, % of -12.41 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.32
- Positive: Inventory ratio change, % of -84.06 <= -1.03
Short-term GERN quotes
Long-term GERN plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1.39MM | $0.60MM | $0.24MM |
Operating Expenses | $115.39MM | $139.15MM | $194.18MM |
Operating Income | $-114.00MM | $-138.55MM | $-193.94MM |
Non-Operating Income | $-3.21MM | $-3.35MM | $9.82MM |
Interest Expense | $3.74MM | $6.88MM | $8.31MM |
R&D Expense | $85.73MM | $95.52MM | $125.05MM |
Income(Loss) | $-117.21MM | $-141.90MM | $-184.13MM |
Profit(Loss) | $-117.21MM | $-141.90MM | $-184.13MM |
Stockholders Equity | $126.42MM | $80.00MM | $247.95MM |
Inventory | $1.40MM | $3.14MM | $0.00MM |
Assets | $226.03MM | $190.57MM | $394.08MM |
Operating Cash Flow | $-95.56MM | $-127.38MM | $-167.74MM |
Capital expenditure | $0.21MM | $0.43MM | $0.83MM |
Investing Cash Flow | $71.95MM | $62.07MM | $-180.32MM |
Financing Cash Flow | $48.56MM | $87.26MM | $362.02MM |
Earnings Per Share* | $-0.37 | $-0.37 | $-0.32 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.